Case Study 2: Comparative Efficacy of Multi-Agonists Semaglutide Single agonist: Targets GLP-1 to boost insulin secretion and reduce appetite
However, researchers soon realised its potential therapeutic use in humans as an anticoagulant
Mounjaro, Zepbound, and Trulicitys labels include robust, FDA-approved warnings, and have always warned of potential gastrointestinal adverse reactions, sometimes severe. He added, As part of our routine safety review process for Mounjaro, Zepbound and Trulicity, we work closely with regulators regarding potential safety topics, and we will continue to review data to ensure that appropriate safety information is available to prescribers. Ana Santos Rutschman, a health law professor at Villanova University, said proving the drugs caused certain outcomes will be an issue as the legal battle unfolds, along with the extent and timing of warnings
Plaintiffs allege the companies misled consumers about the risks associated with the drugs, including potential side effects and safety concerns
